The MSFHR Innovation to Commercialization (I2C) Program provides funding support for translational researchers in the health and health services sectors — to advance their discoveries or inventions towards commercialization resulting in products or technologies that improve health outcomes, and enrich the health innovation ecosystem of BC.The I2C Program is one of six new MSFHR programs developed to meet the specific funding needs of the BC health research community. It allows researchers to protect time to focus on advancing discoveries towards commercialization, providing the opportunity to conduct feasibility research and commercialization activities in order to determine and improve the commercial viability of their intellectual property. It achieves this by providing funding support to a portion of the award recipients’ salaries and/or research personnel directly associated with the award recipient’s proposed research, and for activities directly related to implementation of a commercialization plan.

Program details:

•Annual intake.
•Award term of up to four years.
oPhase I: $150,000/annum for two years.
oPhase II: An additional two years upon successful renewal with a funding partner; MSFHR will match 1:1 up to $75,000/annum for a total of $150,000/annum.
•Eligible to researchers who hold an appointment at an eligible BC university, health authority or research institute and conduct research with a clear link to human health.
•Focus of translational research must be at or past active research and development for proof-of-principle, but not past the level of a successfully-demonstrated product or technology.

Deadlines:

Letter of intent deadline: Mar 9, 2017
Full application deadline: Apr 21, 2017

To learn more and to apply, click here.